Table 1.
Experimental setup | Large anterior PDFMe | Medium-sized anterior PDFMe | Small anterior PDFMe | Large posterior PDFMe | Small posterior PDFMe |
---|---|---|---|---|---|
All experiments (n = 25) | 4.2 ± 1.6; 25 | 3.6 ± 1.0; 24 | 3.9 ± 1.8; 18 | 1.7 ± 1.7; 22 | 2.4 ± 1.3; 22 |
Anti-PDF + anti-FMRFamide (n = 11) | 0 ± 0; 11 | 3.9 ± 0.9; 10 | 4.4 ± 1.3; 10 | 0.1 ± 0.3; 9a | 1.8 ± 1.5; 9b |
Anti-PDF + anti-Asn13 -orcokinin (n = 14) | 0 ± 0; 14 | 4.1 ± 1.1; 10 | 2.5 ± 0.6; 4c | 0 ± 0; 13 | 0.1 ± 0.3; 13d |
aOne large posterior PDFMe was FMRFamide-immunoreactive (ir) in only one case
bOne small posterior PDFMe was not FMRFamide-ir in only one case
cThe small number is attributable to difficulties in evaluation of weakly labeled preparations
dOne small posterior PDFMe was orcokinin-ir in only one case